Donald R. Proctor
Director/Board Member at The Leukemia & Lymphoma Society, Inc.
Profile
Donald R.
Proctor is currently a Director at The Leukemia & Lymphoma Society, Inc. Prior to this, he was a Senior Vice President at Cisco Systems, Inc. from 2012 to 2016.
He received his undergraduate degree from the University of California, Berkeley.
Donald R. Proctor active positions
| Companies | Position | Start |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Director/Board Member | - |
Former positions of Donald R. Proctor
| Companies | Position | End |
|---|---|---|
| CISCO SYSTEMS, INC. | Corporate Officer/Principal | 2016-09-30 |
Training of Donald R. Proctor
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CISCO SYSTEMS, INC. | Electronic Technology |
| Private companies | 1 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
- Stock Market
- Insiders
- Donald R. Proctor
